Skip to main content

Incannex Healthcare Inc. (IXHL) Stock

Incannex Healthcare Inc. Stock Details, Movements and Public Alerts

Stock Details

Incannex Healthcare Inc. (IXHL), a prominent company in the healthcare sector within the drug manufacturers - specialty & generic industry, is based in Australia and primarily trades on the NCM.Currently, the stock is trading at $0.29. Over the past 52 weeks, it has ranged between $0.08 and $2.09. This places the current price at 13.9% of its 52-week high and 262.5% above its 52-week low. Recent trading volume was recorded at 8,337,545. The 14-day Relative Strength Index (RSI) stands at 36.75, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.38 by 23.68%. Similarly, it is below its 200-day moving average of $0.40 by 27.50%. The MACD histogram is -0.01, indicating bearish momentum (MACD Line: -0.03, Signal Line: -0.02). There are currently 2 active alerts set for IXHL by users.

52-Week Range

$2.09 - $0.08

-86.12% from high · +262.50% from low

Avg Daily Volume

8,010,488

20-day average

100-day avg: 20,579,380

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-0.15

Price to Book

1.30

EV/EBITDA

-1.17

EPS (TTM)

-$1.08

Price to Sales

8309.41

Beta

2.59

More volatile than market

Q:How is IXHL valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is IXHL's risk profile compared to the market?
With a beta of 2.59, Incannex Healthcare Inc. is significantly more volatile than the market. For every 10% market move, this stock tends to move 26% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 1.30 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-191625.00%

EBITDA

$-22,850,000

Return on Equity

-114.52%

Return on Assets

-30.33%

Q:How profitable and efficient is IXHL's business model?
0 The operating margin of -191625.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -114.52% and ROA at -30.33%, the company achieves moderate returns on invested capital.
Q:What are IXHL's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$99.7M

Revenue (TTM)

$12,000

Revenue/Share (TTM)

$0.00

Shares Outstanding

346.23M

Book Value/Share

$0.22

Asset Type

EQUITY

Q:What is IXHL's market capitalization and position?
Incannex Healthcare Inc. has a market capitalization of $99.7M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 346.23M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Drug Manufacturers - Specialty & Generic industry, it competes with other firms in this sector.
Q:How does IXHL's price compare to its book value?
Incannex Healthcare Inc.'s book value per share is $0.22, while the current stock price is $0.29, resulting in a price-to-book (P/B) ratio of 1.31. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Feb 8, 2026, 02:01 AM

Technical Indicators

RSI (14-day)

36.75

Neutral

50-Day Moving Average

$0.38

-23.68% below MA-50

200-Day Moving Average

$0.40

-27.50% below MA-200

MACD Line

-0.03

MACD Signal

-0.02

MACD Histogram

-0.01

Bearish

Q:What does IXHL's RSI value tell investors?
The RSI (Relative Strength Index) for IXHL is currently 36.75, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret IXHL's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.03 below the signal line at -0.02, with histogram at -0.01. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.38) is below the 200-day MA ($0.40), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Feb 8, 2026, 12:41 AM

Active Alerts

Alert Condition
Earnings Announcement
Threshold
3 days
Created
Feb 2, 2026, 04:53 PM
Alert Condition
Price increases by
Threshold
20%
Created
Jan 29, 2026, 04:54 PM

Stay Ahead of the Market with Incannex Healthcare Inc. Alerts

Set up price alerts for Incannex Healthcare Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.